Tag Archive for: atai
Math Over Myth: ATAI & Cathie Wood’s Reverse Midas Touch
Business, OPINIONThis morning, ATAI Life Sciences (Nasdaq: ATAI) experienced a shocking drop of nearly 40% in its stock price, plummeting to an all-time low since the company's June 2021 Initial Public Offering. The cause? A failed lead asset from its majority-owned Perception Neuroscience unit.
Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3
Business, Stock ReportsMath over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus, and more
Math Over Myth: Weekly Psychedelic Stocks News Roundup
Business, Stock ReportsGet the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive
Math Over Myth: September Psychedelic Stock News Roundup
Business, Stock ReportsTrack the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup
Math Over Myth: Spotlight on Psychedelic Stocks ATAI & COMPASS
Business, Stock ReportsIf you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep dive on atai Life Sciences & COMPASS Pathways
Psychedelic Stocks: ARK Invest and the Reverse Midas Touch
Business, Investing, Stock ReportsCathie Wood is buying up stocks from the most dubious actors in the psychedelic sector. Given ARK Invest’s subpar performance, is that a good thing?
Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses
Business, Stock ReportsThe psychedelic renaissance hits a rough patch as major companies look to tighten their belts or face total collapse. What’s happening with Psychedelic Stocks?